Literature DB >> 33577244

Bilateral Vestibulopathy in Neuroborreliosis.

Pasquale Malara1, Salvatore Martellucci2, Andrea Castellucci3, Valeria Belvisi4, Aleardo Del Torso1.   

Abstract

OBJECTIVE: To describe a unique case of definite neuroborreliosis presenting with bilateral vestibulopathy (BV) due to simultaneous involvement of both vestibular systems highlighted by a complete assessment for all five vestibular receptors. PATIENT: A 72-year-old woman presented with disabling disequilibrium arisen about 4 weeks earlier and history of erythema migrans developing about 45 days before.
INTERVENTIONS: Assessing all five vestibular receptors with the video-head impulse test (vHIT), the suppression head impulse paradigm (SHIMP) and vestibular evoked myogenic potentials (VEMPs), a severe bilateral vestibulopathy was diagnosed. IgG and IgM Borrelia-specific antibodies on patient serum and cerebrospinal fluid analysis confirmed the diagnosis of neuroborreliosis. Following diagnosis, a course of doxycycline was started and the patients received an individualized vestibular rehabilitation program.
RESULTS: The patient exhibited slowly progressive improvements for disabling symptoms and the improving function of all five vestibular receptors was monitored with vHIT, SHIMP, and VEMPs over time.
CONCLUSIONS: This is the first case report of bilateral vestibulopathy likely caused by neuroborreliosis. Although neurotologic involvement is an uncommon complication in this condition, clinicians should consider a vestibular testing battery when addressed by patient's history and bedside vestibular findings.
Copyright © 2021, Otology & Neurotology, Inc.

Entities:  

Year:  2021        PMID: 33577244     DOI: 10.1097/MAO.0000000000003052

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  1 in total

Review 1.  The Clinical Use of the Suppression Head Impulse Paradigm in Patients with Vestibulopathy: A Systematic Review.

Authors:  Leonardo Manzari; Sara De Angelis; Alessandro Antonio Princi; Giovanni Galeoto; Marco Tramontano
Journal:  Healthcare (Basel)       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.